Haleon
- Market cap
- 39.67B
- P/E (TTM)i
- 18.87
- P/Bi
- 1.83
- EPSi
- 0.49
- Div yieldi
- 2.11%
- 52W posi
- 17%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 18 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.6 percentage points.
Institutional ownership
- Held by institutions
- 93.93% -0.61pp
- Institutions
- 1,059 -18
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
3 filings tracked · 0 buys · 3 sells
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2023-12-26 | Glaxosmithkline (Us) Trust | -- | Intent to Sell (Form 144) | -8,527,104 | $8.28 |
| 2023-12-04 | Gsk Master Grantor Trust | -- | Intent to Sell (Form 144) | -404,599 | $8.57 |
| 2023-11-05 | GlaxoSmithKline Employee Trust | -- | Intent to Sell (Form 144) | -173,611 | $7.96 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:38:25 · For reference only, not investment advice and not tailored to your situation.